BIOLINERX
Facebook
|
Twitter
|
Linkedin
| Careers | Contact Us
search

SEC Filings
Form 6-K
BIOLINERX LTD. filed this Form 6-K on 07/31/2017
Document Outline
Entire Document (566.1 KB)
Subdocument 1 - 6-K - 6-K
Page 1 - N/A
Page 2 - N/A
Page 3 - Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused
Subdocument 2 - EX-5.1 - OPINION OF YIGAL ARNON & CO.
Page 1 - Exhibit 5.1
Page 2 - 1 Azrieli Center, Tel Aviv 67021, Israel | Tel: (+972) 3 608 7777 | Fax: (+972) 3 608 7724 31 Hillel
Subdocument 3 - EX-5.2 - OPINION OF MORRISON & FOERSTER LLP
Page 1 - Exhibit 5.2
Page 2 - /s/ Morrison Foerster LLP
Subdocument 4 - EX-10.1 - SUBSCRIPTION AGREEMENT
Page 1 - Exhibit 10.1
Page 2 - Depositary
Page 3 - N/A
Page 4 - Indemnification
Page 5 - N/A
Page 6 - N/A
Page 7 - phils@biolinerx.com
Page 8 - .pdf
Page 9 - /s/ Philip Serlin
Page 10 - /s/ Mark Lampert
Page 11 - Incorporation and Good Standing of the Company and Its Subsidiaries
Page 12 - Authorized Capital; Options, etc
Page 13 - Validity and Binding Effect of the Agreements
Page 14 - Independent Accountants
Page 15 - Intellectual Property
Page 16 - No Investment Company Status
Page 17 - Financial Statements, etc
Page 18 - Accounting Controls
Subdocument 5 - EX-10.2 - FORM OF SERIES A WARRANT
Page 1 - Exhibit 10.2
Page 2 - Company s Failure to Timely Deliver Securities
Page 3 - Disputes
Page 4 - Other Limitations
Page 5 - PURCHASE RIGHTS; FUNDAMENTAL TRANSACTIONS
Page 6 - REISSUANCE OF WARRANTS
Page 7 - SEVERABILITY
Page 8 - N/A
Page 9 - N/A
Page 10 - N/A
Page 11 - Form of Exercise Price
Page 12 - ACKNOWLEDGMENT The Company hereby acknowledges this Exercise Notice and hereby directs The Bank of N
Subdocument 6 - EX-10.3 - FORM OF SERIES B WARRANT
Page 1 - Exhibit 10.3
Page 2 - Company s Failure to Timely Deliver Securities
Page 3 - Disputes
Page 4 - Other Limitations
Page 5 - PURCHASE RIGHTS; FUNDAMENTAL TRANSACTIONS
Page 6 - REISSUANCE OF WARRANTS
Page 7 - SEVERABILITY
Page 8 - N/A
Page 9 - N/A
Page 10 - N/A
Page 11 - Form of Exercise Price
Page 12 - ACKNOWLEDGMENT The Company hereby acknowledges this Exercise Notice and hereby directs The Bank of N
Subdocument 7 - EX-10.4 - VOTING AND STANDSTILL AGREEMENT
Page 1 - Exhibit 10.4
Page 2 - Subject Securities
Page 3 - N/A
Page 4 - N/A
Page 5 - N/A
Page 6 - /s/ Mark Lampert
Page 7 - /s/ Mark Lampert


Interview with Philip Serlin, CEO
December 2016